HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Astrid Rasmussen Selected Research

Ataxin-10

1/2017Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions.
3/2014Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures.
1/2013Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Astrid Rasmussen Research Topics

Disease

6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 04/2012
4Spinocerebellar Ataxia 10
01/2020 - 01/2013
4Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2017 - 06/2007
2Sarcoidosis (Schaumann Disease)
10/2022 - 01/2020
2Autoimmune Diseases (Autoimmune Disease)
03/2017 - 01/2015
2Cerebellar Ataxia (Dysmetria)
01/2017 - 01/2013
2Juvenile Myoclonic Epilepsy
05/2009 - 09/2006
1Tuberculosis (Tuberculoses)
10/2022
1Myotonic Dystrophy (Dystrophia Myotonica)
01/2022
1Fatigue
12/2021
1Dry Eye Syndromes (Dry Eye Syndrome)
10/2021
1Corneal Injuries
07/2020
1Lymphadenopathy
01/2020
1Fibrosis (Cirrhosis)
05/2018
1Rheumatoid Arthritis
03/2017
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2016
1Xerostomia
03/2016
1Sialadenitis
03/2016
1Lymphoma (Lymphomas)
03/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2014
1Hemangioblastoma
04/2010
1Parkinson Disease (Parkinson's Disease)
02/2007
1Idiopathic Generalized Epilepsy
09/2006
1Alzheimer Disease (Alzheimer's Disease)
07/2006
1Epilepsy (Aura)
01/2003
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
05/2002

Drug/Important Bio-Agent (IBA)

4AutoantibodiesIBA
01/2018 - 12/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2009
3Ataxin-10IBA
01/2017 - 01/2013
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
2Proteins (Proteins, Gene)FDA Link
12/2021 - 03/2014
2PENTAIBA
01/2017 - 03/2014
1HLA-DRB1 Chains (HLA DRB1)IBA
10/2022
1AntibodiesIBA
10/2021
1SS-A antibodiesIBA
07/2020
1P-2 (P 2)IBA
01/2020
1Biological ProductsIBA
01/2020
1Eosine Yellowish-(YS) (Eosin)IBA
05/2018
1ElementsIBA
05/2018
1Interferon Type IIBA
03/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017
1Pilocarpine (Ocusert)FDA LinkGeneric
03/2016
1Rheumatoid FactorIBA
03/2016
1NADPH Oxidases (NAD(P)H oxidase)IBA
03/2014
1Transcription Factors (Transcription Factor)IBA
03/2014
1InterferonsIBA
04/2012
1AutoantigensIBA
04/2012
1Retinaldehyde (Retinal)IBA
04/2010
1tributyl phosphate (TBP)IBA
06/2007
1Apolipoproteins E (ApoE)IBA
02/2007
1ApolipoproteinsIBA
02/2007
1Immunoglobulin E (IgE)IBA
09/2006
1Presenilin-1IBA
07/2006
1Genetic Markers (Genetic Marker)IBA
01/2003
1Dual-Specificity PhosphatasesIBA
05/2002

Therapy/Procedure

1Immunotherapy
01/2015